Details for: LY6G6F LY6G6D

Gene ID: 110599563

Gene Type:  Protein-coding  - A gene that serves as a template for producing a messenger RNA (mRNA) molecule, which is then translated into a functional protein.

Symbol: LY6G6F LY6G6D

Ensembl ID: ENSG00000250641

Description: LY6G6F-LY6G6D readthrough

Selected Context(s):  Overall

Cell Significance Landscape

Contexts:

Significant Cells

Cell Significance Index (CSI) scores for the chosen context(s)

  • megakaryocyte CL0000556
    CSI 1.5
    rCSI 6.52%
    PRS 99.85

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this specific cell.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Network Configuration

Explore relationships of the current gene. Select an Interaction Source: 'ONTOLOGY' for shared pathways (GO/Reactome) or 'STRING' for protein-protein interactions. Further refine by selecting context genes and comparing Cell Significance Index (CSI) scores between baseline and target cell types and their specific contexts.

Comma-separated if multiple.
Comma-separated if multiple.
Legend:
  • Query Gene
  • Node Color (Target Cell CSI, relative to current network):
    • Very High
    • High
    • Medium
    • Low
    • Very Low
    • CSI N/A
  • Node Size: Proportional to Target Cell CSI magnitude
  • STRING PPI Edge
  • Shared Pathway Edge (ONTOLOGY)

Loading network (please wait)...

Other Information

This section provides additional information about the gene, including a description generated by an AI language model and details about associated proteins.

## Summary The `[LY6G6F LY6G6D](/details-gene/110599563)` gene, located on chromosome 6p21.33, is a protein-coding gene notable for being transcribed as a readthrough transcript from two adjacent LY6 gene family members, LY6G6F and LY6G6D. The function of this specific readthrough product is not yet fully characterized. However, expression analysis indicates a highly specific and significant role within the hematopoietic system. **Overall**, the transcript is identified as a key marker for the [megakaryocyte](/details-cell/CL0000556) lineage, suggesting its primary involvement in the biology of platelet-producing cells. ## Cellular Roles and Expression Landscape The expression profile of `[LY6G6F LY6G6D](/details-gene/110599563)` is characterized by its remarkable specificity for a single cell type within the hematopoietic compartment. **Overall**, comprehensive analysis of expression data identifies `[LY6G6F LY6G6D](/details-gene/110599563)` as a significant marker exclusively in [megakaryocyte](/details-cell/CL0000556) (CSI: 1.50). This high degree of specificity suggests that the gene product is not a general housekeeping protein but rather performs a specialized function integral to the identity or activity of this particular cell lineage. The absence of significant expression in other cell types underscores its potential role as a defining feature of megakaryocytes. ## Pathways and Molecular Function The precise molecular functions and biological pathways associated with the `[LY6G6F LY6G6D](/details-gene/110599563)` readthrough transcript are not well-defined in available functional annotation databases. However, its highly specific expression in [megakaryocyte](/details-cell/CL0000556) strongly suggests a functional role in processes central to this lineage. These may include the regulation of megakaryopoiesis (the differentiation of hematopoietic stem cells into mature megakaryocytes), endomitosis (the process of DNA replication without cell division leading to polyploidy), or the formation of proplatelets, which are the cytoplasmic extensions from which platelets are shed into the bloodstream. ## Research Directions The unique expression pattern of `[LY6G6F LY6G6D](/details-gene/110599563)` in [megakaryocyte](/details-cell/CL0000556) makes it an intriguing subject for further investigation, particularly concerning hematopoietic development and related pathologies. **Proposed Hypotheses:** 1. The `[LY6G6F LY6G6D](/details-gene/110599563)` readthrough transcript is essential for the terminal maturation and polyploidization of [megakaryocyte](/details-cell/CL0000556), and its absence would lead to impaired development. 2. The protein product of `[LY6G6F LY6G6D](/details-gene/110599563)` localizes to the demarcation membrane system or cytoskeleton and plays a direct role in the mechanics of proplatelet formation and platelet release. **Key Experimental Approach:** To test the hypothesis that `[LY6G6F LY6G6D](/details-gene/110599563)` is critical for megakaryocyte maturation, a loss-of-function study could be performed. Human CD34+ hematopoietic stem and progenitor cells could be isolated and transduced with lentiviral vectors carrying CRISPR-Cas9 constructs targeting the unique exons of the readthrough transcript. Following selection, these modified cells would be cultured *in vitro* with thrombopoietin and other cytokines to induce differentiation into the megakaryocytic lineage. The functional consequences of the knockout would be assessed by quantifying cell ploidy via flow cytometry, analyzing the expression of mature megakaryocyte markers (e.g., CD41a, CD42b), and visualizing proplatelet formation using immunofluorescence microscopy. **Therapeutic Potential:** Given its highly restricted expression, `[LY6G6F LY6G6D](/details-gene/110599563)` could serve as a highly specific biomarker for the [megakaryocyte](/details-cell/CL0000556) lineage. If its function is proven to be critical for platelet production, it may represent a potential therapeutic target for disorders of platelet count. For instance, in conditions of thrombocythemia (excess platelets), inhibiting the function of this gene could selectively reduce platelet production with minimal off-target effects. Conversely, if it is a positive regulator, its activation could be explored in certain forms of thrombocytopenia. However, a detailed understanding of its molecular function is a prerequisite for any therapeutic development.